ViewRay logo
ViewRay VRAY

Quarterly report 2023-Q1
added 05-11-2023

report update icon

ViewRay Balance Sheet 2011-2026 | VRAY

Annual Balance Sheet ViewRay

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-59.8 M -162 M -99.2 M -171 M -112 M -12.9 M 30.1 M 8.35 M -727 -508 - -

Long Term Debt

73.3 M 54 M 56.9 M 54 M 55.4 M 44.5 M 44.3 M 29 M - - - -

Long Term Debt Current

2.86 M 2.56 M 2.09 M 2.26 M - - - - - - - -

Total Non Current Liabilities

- - - 74.8 M 73.8 M 77.5 M 55.2 M 31 M - - - -

Total Current Liabilities

96.6 M 76.2 M 56.9 M 59.1 M 53.9 M 56.2 M 37.2 M 28.2 M 7.28 K - - -

Total Liabilities

189 M 152 M 131 M 134 M 128 M 134 M 92.4 M 59.1 M 7.28 K 2.7 K - -

Deferred Revenue

24.7 M 13.9 M 25.6 M 20.1 M 33.7 M 38 M 25.9 M 18.4 M - - - -

Retained Earnings

-844 M -737 M -627 M -519 M -399 M -320 M -248 M -197 M -24.9 K -471 - -

Total Assets

271 M 322 M 262 M 350 M 295 M 136 M 48.8 M 52.2 M 10.4 K 5.73 K - -

Cash and Cash Equivalents

136 M 218 M 158 M 227 M 167 M 57.4 M 14.2 M 20.7 M 11.1 M 26.5 M - -

Book Value

82.2 M 170 M 130 M 216 M 167 M 1.99 M -43.7 M -6.96 M 3.17 K 3.03 K - -

Total Shareholders Equity

82.2 M 170 M 130 M 216 M 167 M 1.99 M -43.7 M -6.96 M -151 M -117 M - -

All numbers in USD currency

Quarterly Balance Sheet ViewRay

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 73.3 M - - 49.3 M 54 M 57.2 M 57.1 M 57 M 56.9 M 56.9 M 56.9 M 56.9 M 54 M 54 M 54 M 54 M 55.4 M 55.4 M 55.4 M 55.4 M 44.5 M 44.5 M 44.5 M 44.5 M 44.3 M 44.3 M 44.3 M 44.3 M 29 M 29 M 29 M 29 M 9.15 M 9.15 M - - - - - - - - - - - - - -

Total Liabilities

178 M 189 M - - 151 M 152 M 142 M 135 M 123 M 131 M 131 M 131 M 131 M 134 M 134 M 134 M 134 M 128 M 128 M 128 M 128 M 134 M 134 M 134 M 134 M 92.4 M 92.4 M 92.4 M 92.4 M 59.1 M 59.1 M 59.1 M 59.1 M 39.6 M 39.6 M 7.28 K 7.28 K 2.7 K 2.7 K 2.7 K - - - - - - - - -

Deferred Revenue

23.9 M 24.7 M - - 13.9 M 13.9 M 12.5 M 11 M 10 M 10.1 M 10.1 M 10.1 M 10.1 M 10.5 M 10.5 M 10.5 M 10.5 M 13.7 M 11.3 M 15.5 M 9.67 M 20.2 M 10.9 M 20.2 M 20.2 M 6.52 M 6.52 M 6.52 M 6.52 M 5.62 M 5.62 M 5.62 M 5.62 M 7.36 M 7.36 M - - - - - - - - - - - - - -

Retained Earnings

-873 M -844 M - - -763 M -737 M -710 M -685 M -654 M -627 M -627 M -627 M -627 M -519 M -519 M -519 M -519 M -399 M -399 M -399 M -399 M -320 M -320 M -320 M -320 M -248 M -248 M -248 M -248 M -197 M -197 M -197 M -197 M -152 M -152 M -24.9 K -24.9 K -471 -471 -471 - - - - - - - - -

Total Assets

233 M 271 M - - 298 M 322 M 260 M 274 M 288 M 262 M 262 M 262 M 262 M 350 M 350 M 350 M 350 M 295 M 295 M 295 M 295 M 136 M 136 M 136 M 136 M 48.8 M 48.8 M 48.8 M 48.8 M 52.2 M 52.2 M 52.2 M 52.2 M 34.1 M 34.1 M 10.4 K 10.4 K 5.73 K 5.73 K 5.73 K - - - - - - - - -

Cash and Cash Equivalents

81.3 M 136 M - - 185 M 218 M 150 M 167 M 182 M 157 M 157 M 157 M 157 M 227 M 227 M 227 M 227 M 167 M 167 M 167 M 167 M 57.4 M 57.4 M 57.4 M 57.4 M 14.2 M 14.2 M 14.2 M 14.2 M 20.7 M 20.7 M 20.7 M 20.7 M 11.1 M 11.1 M 7.93 K 7.93 K 26.5 M 3.21 K 3.21 K - 4.1 M - - - - - - -

Book Value

55.3 M 82.2 M - - 148 M 170 M 118 M 139 M 164 M 130 M 130 M 130 M 130 M 216 M 216 M 216 M 216 M 167 M 167 M 167 M 167 M 1.99 M 1.99 M 1.99 M 1.99 M -43.7 M -43.7 M -43.7 M -43.7 M -6.96 M -6.96 M -6.96 M -6.96 M -5.51 M -5.51 M 3.17 K 3.17 K 3.03 K 3.03 K 3.03 K - - - - - - - - -

Total Shareholders Equity

55.3 M 82.2 M - - 148 M 170 M 118 M 139 M 164 M 130 M 130 M 130 M 130 M 216 M 216 M 216 M 216 M 167 M 167 M 167 M 167 M 1.99 M 1.99 M 1.99 M 1.99 M -43.7 M -43.7 M -43.7 M -43.7 M -6.96 M -6.96 M -6.96 M -6.96 M -151 M -151 M 3.17 K - -117 M 3.03 K 3.03 K - -89.3 M - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of ViewRay, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 26.39 -1.46 % $ 604 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 21.64 -7.2 % $ 1.47 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 35.8 -2.29 % $ 1.11 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 2.21 -2.64 % $ 130 M israelIsrael
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Electromed Electromed
ELMD
$ 24.35 -0.41 % $ 206 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Viemed Healthcare Viemed Healthcare
VMD
$ 9.26 0.43 % $ 360 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.78 - $ 446 M usaUSA
Outset Medical Outset Medical
OM
$ 3.39 -3.69 % $ 51.6 K usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 1.17 -2.03 % $ 5.87 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.61 0.82 % $ 33.2 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.26 -0.44 % $ 3.53 M usaUSA
PAVmed PAVmed
PAVM
$ 8.77 -1.9 % $ 63.4 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
InspireMD InspireMD
NSPR
$ 1.67 -3.47 % $ 107 M israelIsrael
Beyond Air Beyond Air
XAIR
$ 0.67 -2.84 % $ 45.4 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.25 -1.4 % $ 1.52 B usaUSA
Penumbra Penumbra
PEN
$ 335.34 -0.32 % $ 13.1 B usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 87.82 -1.49 % $ 17.8 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.82 -3.05 % $ 565 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
Myomo Myomo
MYO
$ 0.68 -0.31 % $ 28.5 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.64 -14.68 % $ 30 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 49.12 -2.54 % $ 1.44 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.2 -3.33 % $ 48.8 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA